دورية أكاديمية

IDF2022-0687 Characterization and efficacy of GNTI-122, a novel engineered regulatory T-cell therapy, for treating Type 1 Diabetes

التفاصيل البيبلوغرافية
العنوان: IDF2022-0687 Characterization and efficacy of GNTI-122, a novel engineered regulatory T-cell therapy, for treating Type 1 Diabetes
المؤلفون: Uenishi, G., Landuyt, A., Yam, J., Saikumar-Lakshmi, P., Guo, T., Kieffer-Kwon, P., Chen, T., Repic, M., Wickham, T., Mueller, K.
المصدر: In Diabetes Research and Clinical Practice March 2023 197 Supplement 1
قاعدة البيانات: ScienceDirect
الوصف
تدمد:01688227
DOI:10.1016/j.diabres.2023.110277